{"transactions":[{"id":2008107,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":116758,"kind":"person","name":"Nazak Michael Adrian","position":1,"cik":"0001799731","reported_name":"Nazak Michael Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-18T00:23:22.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":16600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from January 1, 2023."}],"balance_after":16600,"derivative":{"exercise_price":14.29,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":16600},"source":{"system":"sec-edgar","filing":"0000899243-23-005550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000089924323005550/doc4.xml","form_type":"4"}},{"id":2270602,"issuer":{"id":1085,"kind":"organization","name":"AN2 Therapeutics, Inc.","symbol":"ANTX"},"owners":[{"id":116758,"kind":"person","name":"Nazak Michael Adrian","position":1,"cik":"0001799731","reported_name":"Nazak Michael Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-17T01:21:41.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":14300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from March 25, 2022."}],"balance_after":14300,"derivative":{"exercise_price":17.28,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":14300},"source":{"system":"sec-edgar","filing":"0000899243-22-018287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000089924322018287/doc4.xml","form_type":"4"}},{"id":2843462,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":116758,"kind":"person","name":"Nazak Michael Adrian","position":1,"cik":"0001799731","reported_name":"Nazak Michael Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-02-22T20:08:07.000Z","date":"2021-02-18","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in equal installments over 48 months, beginning on February 1, 2021."}],"balance_after":80000,"derivative":{"exercise_price":7.84,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-026339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799731/000110465921026339/a4.xml","form_type":"4"}},{"id":3312670,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":116758,"kind":"person","name":"Nazak Michael Adrian","position":1,"cik":"0001799731","reported_name":"Nazak Michael Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2020-01-13T16:02:43.000Z","date":"2020-01-02","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in equal installments over 48 months, beginning on January 2, 2020."}],"balance_after":60000,"derivative":{"exercise_price":4.45,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-003445","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799731/000110465920003445/a4.xml","form_type":"4"}}]}